Primary Results Of Solti-1503 Prometeo Phase 2 Trial Of Combination Of Talimogene Laherparepvec (T-Vec) With Atezolizumab In Patients With Residual Breast Cancer After Standard Neoadjuvant Multi-Agent Chemotherapy
Atezolizumab;Talimogene Laherparepvec
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Primary Results Of Solti-1503 Prometeo Phase 2 Trial Of Combination Of Talimogene Laherparepvec (T-Vec) With Atezolizumab In Patients With Residual Breast Cancer After Standard Neoadjuvant Multi-Agent Chemotherapy ### Output: Atezolizumab;Talimogene Laherparepvec